Actionable news
All posts from Actionable news
Actionable news in ZGNX: Zogenix, Inc.,

FDA Seeks More Information on Zogenix Trials

Zogenix Inc. said the U.S. Food and Drug Administration has requested additional information related to clinical trials of a treatment for a rare form of epilepsy.

In after-hours trading, Zogenix shares were down 10.4% to $12.30.

The company said Monday it is "confident that we have adequately addressed the FDA's information requests." Zogenix said the clinical development timeline remains unchanged for ZX008, which is being developed as a treatment for Dravey syndrome.

The FDA is seeking...